1.
Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients with COVID -19. Journal of Pharmaceutical Negative Results [Internet]. 2022 Jun. 30 [cited 2026 Jun. 10];13(2):82-6. Available from: https://pnrjournal.com/index.php/home/article/view/199